RASSF5 and neoplasm: Instead, SAV1 SARAH and MST2 SARAH form a heterodimer, similar to that formed by the SARAH domains of MST2 and one of the RASSF family of tumor suppressors, RASSF5 (Figure 4C and D) (Ni et al., 2013).